Table 1. Baseline characteristics of 206 patients with stroke.
N=206 | |
Age (years), medians (IQRs) | 59(48-73) |
Sex-male, n (%) | 112(54.4) |
BMI (kg/m2), medians (IQRs) | 26.7(24.8-28.2) |
Time from onset to blood collection(hours), medians (IQRs) | 22.5(13.0-28.5) |
Vascular risk factors, n (%) | |
Hypertension | 141(68.4) |
Hypercholesterolemia | 55(26.7) |
Atrial fibrillation | 46(22.3) |
Coronary heart disease | 22(11.7) |
Previous TIA | 25(12.1) |
PVD | 11(5.3) |
Acute treatment, no. (%) | |
TPA-T | 52(25.2) |
Mechanical thrombectomy | 9(4.4) |
Mechanical thrombectomy and/or TPA-T | 57(27.7) |
NIHSS at admission, medians (IQR) | 7(4-12) |
Lesion volumes (ml), median (IQR) | 21.8(8.6-35.9) |
Stroke etiology no. (%) | |
Small-vessel occlusive | 42(20.4) |
Large-vessel occlusive | 40(19.4) |
Cardioembolic | 77(37.4) |
Other | 20(9.7) |
Unknown | 27(13.1) |
Laboratory findings, medians (IQR) | |
Hs-CRP, mg/dl | 0.74(0.27-1.87) |
HCY, umol/l | 16.6(12.4-20.5) |
FABP4, ng/ml | 17.7(12.7-22.8) |
IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; TPA-T: Tissue plasminogen activator-treated; Hs-CRP, high C-reactive protein; HCY, homocysteine; TIA, Transient ischemic attack; PVD, peripheral vascular disease; FABP4; Fatty Acid Binding Protein 4.